Positron Emission Tomography (PET) Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Positron Emission Tomography (PET) market size was valued at USD 784.5 million in 2022 and is forecast to a readjusted size of USD 975.2 million by 2029 with a CAGR of 3.2% during review period.

PET scanner is a type of nuclear medicine imaging. The scan uses a special dye that has radioactive tracers.

Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.

Market competition is intense. GE, Siemens Healthcare, Philips Healthcare are the leaders of the industry. The clear market leader is GE, which holds a 37% market share. In second place is Siemens Healthcare with a 31% market share, while Philips Healthcare has a strong presence in the market. North America is the largest sales place, with a sales market share nearly 50%. Following USA, Europe is the second largest sales place with the sales market share of 23%.

This report is a detailed and comprehensive analysis for global Positron Emission Tomography (PET) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Positron Emission Tomography (PET) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Positron Emission Tomography (PET) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Positron Emission Tomography (PET) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Positron Emission Tomography (PET) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Positron Emission Tomography (PET)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Positron Emission Tomography (PET) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   GE
   Siemens Healthcare
   Philips Healthcare
   Toshiba
   Hitachi
   Neusoft
   Topgrade HealthCare
   United Imaging

   PET-CT
   PET-MR
   Others

   Oncology
   Cardiology
   Neurology
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the PET market in 2025?

The strength of the PET market lies in its advanced imaging capabilities, providing high precision in diagnosing diseases like cancer, cardiovascular conditions, and neurological disorders. It offers early detection, which is critical for effective treatment planning. The ongoing technological advancements in PET scanners also enhance efficiency, improving patient outcomes and broadening its clinical applications.

What are the weaknesses of the PET market in 2025?

The main weakness is the high cost of PET scans, which limits accessibility in low-resource settings. Additionally, the need for specialized facilities and trained professionals increases operational costs. Limited availability of radiopharmaceuticals and reliance on nuclear technology can also hinder widespread adoption.

What are the opportunities for the PET market in 2025?

Opportunities include the growing demand for personalized medicine, where PET’s ability to track biological processes plays a pivotal role in tailored treatment plans. Advances in radiotracers and hybrid technologies like PET/MRI offer new diagnostic potentials. As healthcare systems continue to adopt cutting-edge technology, the market is expected to expand, especially in emerging economies.

What are the threats to the PET market in 2025?

Threats to the market include competition from alternative imaging techniques like CT scans and MRIs, which are more cost-effective and widely available. Regulatory hurdles around the use of radioactive materials and the potential for supply chain disruptions in the production of radiopharmaceuticals also pose challenges. Additionally, the growing concern over patient safety and radiation exposure could limit market growth.

What are the political factors influencing the PET market in 2025?

Political factors play a role through government regulations around medical imaging technologies and radioactive materials. Strict policies regarding the approval and use of radiopharmaceuticals, as well as funding for healthcare infrastructure, can either encourage or limit the market growth. Additionally, healthcare policies that prioritize advanced diagnostic technologies may boost the adoption of PET.

How do economic factors impact the PET market in 2025?

Economic factors like healthcare funding and reimbursement policies significantly affect the affordability and accessibility of PET scans. In developed countries with strong healthcare systems, PET technologies are more likely to be covered by insurance, promoting adoption. However, in low- and middle-income regions, the high costs of PET machines and radiopharmaceuticals could restrict market penetration.

What social factors affect the PET market in 2025?

Increasing health awareness and the demand for early disease detection contribute to the growing need for advanced diagnostic technologies like PET. Social factors such as a growing aging population and a rise in chronic diseases, like cancer and heart conditions, also drive demand for precise and non-invasive diagnostic tools. Patient preferences for personalized medicine and non-invasive procedures further enhance PET's market potential.

How do technological factors influence the PET market in 2025?

Technological advancements in PET imaging systems, such as higher resolution scanners and hybrid technologies (e.g., PET/MRI), will significantly enhance the market’s growth. The development of new radiotracers improves diagnostic accuracy, while innovations in image processing and artificial intelligence (AI) contribute to more efficient use of PET scans. These technologies make PET a more attractive option for healthcare providers and patients alike.

What environmental factors affect the PET market in 2025?

Environmental concerns around the disposal of radioactive materials and the carbon footprint of PET machines are becoming more prominent. As environmental regulations tighten, companies in the PET market will need to focus on sustainable practices, including better waste management for radiopharmaceuticals and more energy-efficient machines. The shift towards eco-friendly practices may influence market strategies and innovations.

What legal factors impact the PET market in 2025?

Legal factors, including the regulation of radioactive substances, licensing requirements for PET centers, and patent laws around PET technology, are crucial. Compliance with international standards for radiation safety and imaging procedures is mandatory. Moreover, intellectual property rights related to new innovations in PET technologies and radiopharmaceuticals could impact market competition and accessibility.

Who are the suppliers in the PET market in 2025?

Suppliers in the PET market include manufacturers of PET scanning machines, radiopharmaceutical companies that produce tracers, and suppliers of the necessary infrastructure and technology like radiation detectors, imaging software, and maintenance services for the equipment.

Who are the inputs in the PET market in 2025?

The inputs to the PET market are advanced imaging technology, radiopharmaceuticals (like fluorodeoxyglucose or FDG), medical-grade equipment, trained healthcare professionals, regulatory approvals, and raw materials for manufacturing PET machines and related components.

What are the processes in the PET market in 2025?

The key processes involve the production and supply of radiopharmaceuticals, the installation and calibration of PET scanners, patient scheduling and preparation, image acquisition and processing, diagnosis interpretation, and post-scan follow-up. Quality control of equipment and adherence to safety protocols for radioactive materials are also critical steps.

Who are the customers in the PET market in 2025?

Customers in the PET market include hospitals, diagnostic imaging centers, oncology centers, and research institutions. Healthcare providers, particularly oncologists, neurologists, and cardiologists, who rely on high-precision diagnostic tools, are the main users of PET technology.

What are the outputs of the PET market in 2025?

The outputs of the PET market are high-quality diagnostic images that assist in detecting and monitoring diseases such as cancer, neurological disorders, and heart diseases. These images enable clinicians to make informed treatment decisions, improving patient outcomes. Additionally, ongoing research outputs, like new imaging techniques and radiotracers, contribute to the development of the market.

What is the threat of new entrants in the PET market in 2025?

The threat of new entrants in the PET market is relatively low due to high barriers to entry, such as the significant capital investment required for developing and manufacturing PET scanners, the complexity of radiopharmaceutical production, and stringent regulatory requirements. Established players with strong brand recognition and advanced technology have a competitive edge.

How intense is the rivalry among existing competitors in the PET market in 2025?

Rivalry among existing competitors in the PET market is moderate to high, driven by the presence of major players such as GE Healthcare, Siemens Healthineers, and Philips, who compete for market share in both developed and emerging markets. The constant innovation in imaging technologies, radiotracers, and diagnostic capabilities keeps competition fierce. However, the high capital investment and specialized nature of the market limit the number of direct competitors.

What is the bargaining power of suppliers in the PET market in 2025?

The bargaining power of suppliers is moderate to high, particularly for manufacturers of radiopharmaceuticals and key components of PET scanners. Since there are limited suppliers for certain radiotracers and components, suppliers hold significant power in determining prices. However, as technology advances, alternative suppliers and new technologies could gradually reduce this power.

What is the bargaining power of buyers in the PET market in 2025?

The bargaining power of buyers is moderate. While healthcare providers and diagnostic centers have some leverage in negotiating prices, particularly for large-volume purchases or long-term contracts, the high cost of PET machines and radiopharmaceuticals limits their ability to push prices down. Additionally, the unique diagnostic value of PET scans means that buyers often have limited alternatives.

What is the threat of substitute products or services in the PET market in 2025?

The threat of substitutes in the PET market is moderate. While alternative imaging techniques like MRI and CT scans provide valuable diagnostic insights, they do not offer the same level of precision for certain conditions, particularly cancer detection and neurological disorders. However, advancements in these technologies may improve their capabilities, which could increase competition for PET in some applications.

What are the key suppliers in the upstream PET market in 2025?

The key suppliers in the upstream PET market include manufacturers of PET scanning machines, producers of radiopharmaceuticals (such as FDG), and companies that supply the specialized materials and technology needed for the production and maintenance of PET systems. This also includes suppliers of advanced imaging software, radiation detectors, and raw materials for PET machine construction.

What raw materials are essential in the PET market in 2025?

The essential raw materials for the PET market include advanced metals and alloys used in the construction of PET machines, as well as the chemicals required for creating radiotracers (e.g., fluorine-18). Additionally, specialized components such as detectors, electronics, and imaging software play a significant role in the upstream supply chain.

What are the key technological inputs for the PET market in 2025?

Technological inputs include advancements in PET imaging systems, such as improved resolution detectors and hybrid imaging technologies like PET/MRI. Innovation in radiopharmaceuticals, particularly the development of new tracers for specific diseases, and advancements in image processing algorithms, also drive the upstream supply chain.

What are the challenges faced by suppliers in the upstream PET market in 2025?

Suppliers in the upstream PET market face challenges related to the high cost of producing radiopharmaceuticals, which are subject to regulatory approvals and limited shelf life. Additionally, there are technical challenges in maintaining the accuracy and quality of imaging systems. Supply chain disruptions, especially related to the availability of raw materials or specialized components, can also impact production and delivery timelines.

What are the trends driving the upstream PET market in 2025?

Trends driving the upstream PET market include increasing demand for precision diagnostics and personalized medicine, leading to more advanced PET technologies. There is also a growing focus on improving radiopharmaceuticals to target a wider range of diseases. Innovations in hybrid imaging systems and software, along with efforts to improve cost-efficiency and sustainability in production, are also major trends shaping the upstream market.

What are the main players in the midstream PET market in 2025?

The main players in the midstream PET market include diagnostic imaging centers, hospitals, and oncology or cardiology clinics where PET scans are performed. Additionally, radiopharmaceutical distributors who provide the necessary tracers to healthcare facilities are also key midstream participants in the PET market.

What are the key activities in the midstream PET market in 2025?

Key activities in the midstream PET market include the operation of PET scanning machines, patient scheduling and preparation, the administration of radiotracers, image acquisition, and the analysis of scan results by specialized medical professionals. These activities ensure the effective use of PET technology for disease diagnosis and treatment planning.

What challenges do midstream players face in the PET market in 2025?

Midstream players face challenges related to the high cost of PET scanning, which can limit patient access. Additionally, the logistics of managing the supply and handling of radiopharmaceuticals, which have a short shelf life and require strict handling protocols, can be difficult. There is also a need for specialized staff and continuous training to ensure the accuracy and safety of PET procedures.

What are the trends influencing the midstream PET market in 2025?

Trends influencing the midstream PET market include increasing demand for personalized medicine, where PET plays a crucial role in tailoring treatment plans. The rise of hybrid imaging systems like PET/MRI is also creating new opportunities for more precise diagnostics. Additionally, the growing integration of artificial intelligence in image analysis is improving the efficiency and accuracy of PET scans.

What role does regulation play in the midstream PET market in 2025?

Regulation plays a significant role in ensuring the safe and effective use of PET technology. This includes guidelines for radiation safety, the handling and storage of radiopharmaceuticals, and accreditation requirements for PET centers. Regulatory bodies also oversee the quality and accuracy of diagnostic procedures to maintain patient safety and uphold the credibility of the results.

Who are the primary consumers in the downstream PET market in 2025?

The primary consumers in the downstream PET market include healthcare providers such as hospitals, oncology clinics, cardiology centers, and research institutions. These consumers rely on PET scans for early disease detection, treatment monitoring, and clinical research, especially in oncology, neurology, and cardiology.

What are the main services provided in the downstream PET market in 2025?

The main services in the downstream PET market include diagnostic imaging, interpretation of PET scans by specialized radiologists, and follow-up consultations for treatment planning. These services are crucial for guiding clinicians in making accurate diagnoses, selecting personalized treatments, and monitoring disease progression over time.

What challenges do downstream players face in the PET market in 2025?

Downstream players face challenges related to the high costs of PET scans, which may limit patient access in certain regions. Additionally, the availability and timely delivery of radiopharmaceuticals, which are critical for PET scans, can be a logistical challenge. Another hurdle is the need for skilled professionals to interpret PET images accurately, which can create bottlenecks in service delivery.

What trends are shaping the downstream PET market in 2025?

Trends in the downstream PET market include the growing demand for non-invasive, accurate diagnostic tools, driven by the increasing prevalence of chronic diseases like cancer. The integration of AI for image interpretation is also becoming more common, improving efficiency and diagnostic accuracy. Additionally, as personalized medicine continues to gain traction, the demand for PET scans to guide tailored treatment plans is on the rise.

What impact do patient preferences have on the downstream PET market in 2025?

Patient preferences are influencing the downstream PET market by driving demand for minimally invasive diagnostic techniques that provide high levels of accuracy. As patients seek more effective and non-invasive options for early detection and monitoring, PET’s role in cancer, heart disease, and neurological disorders is increasingly valued. Moreover, patients’ increasing awareness of personalized treatment options encourages more reliance on advanced imaging technologies like PET.

Chapter 1, to describe Positron Emission Tomography (PET) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Positron Emission Tomography (PET), with price, sales, revenue and global market share of Positron Emission Tomography (PET) from 2018 to 2023.
Chapter 3, the Positron Emission Tomography (PET) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Positron Emission Tomography (PET) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Positron Emission Tomography (PET) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Positron Emission Tomography (PET).
Chapter 14 and 15, to describe Positron Emission Tomography (PET) sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Positron Emission Tomography (PET)
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Positron Emission Tomography (PET) Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 PET-CT
       1.3.3 PET-MR
       1.3.4 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Positron Emission Tomography (PET) Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Oncology
       1.4.3 Cardiology
       1.4.4 Neurology
       1.4.5 Others
   1.5 Global Positron Emission Tomography (PET) Market Size & Forecast
       1.5.1 Global Positron Emission Tomography (PET) Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Positron Emission Tomography (PET) Sales Quantity (2018-2029)
       1.5.3 Global Positron Emission Tomography (PET) Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 GE
       2.1.1 GE Details
       2.1.2 GE Major Business
       2.1.3 GE Positron Emission Tomography (PET) Product and Services
       2.1.4 GE Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 GE Recent Developments/Updates
   2.2 Siemens Healthcare
       2.2.1 Siemens Healthcare Details
       2.2.2 Siemens Healthcare Major Business
       2.2.3 Siemens Healthcare Positron Emission Tomography (PET) Product and Services
       2.2.4 Siemens Healthcare Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Siemens Healthcare Recent Developments/Updates
   2.3 Philips Healthcare
       2.3.1 Philips Healthcare Details
       2.3.2 Philips Healthcare Major Business
       2.3.3 Philips Healthcare Positron Emission Tomography (PET) Product and Services
       2.3.4 Philips Healthcare Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Philips Healthcare Recent Developments/Updates
   2.4 Toshiba
       2.4.1 Toshiba Details
       2.4.2 Toshiba Major Business
       2.4.3 Toshiba Positron Emission Tomography (PET) Product and Services
       2.4.4 Toshiba Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Toshiba Recent Developments/Updates
   2.5 Hitachi
       2.5.1 Hitachi Details
       2.5.2 Hitachi Major Business
       2.5.3 Hitachi Positron Emission Tomography (PET) Product and Services
       2.5.4 Hitachi Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Hitachi Recent Developments/Updates
   2.6 Neusoft
       2.6.1 Neusoft Details
       2.6.2 Neusoft Major Business
       2.6.3 Neusoft Positron Emission Tomography (PET) Product and Services
       2.6.4 Neusoft Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Neusoft Recent Developments/Updates
   2.7 Topgrade HealthCare
       2.7.1 Topgrade HealthCare Details
       2.7.2 Topgrade HealthCare Major Business
       2.7.3 Topgrade HealthCare Positron Emission Tomography (PET) Product and Services
       2.7.4 Topgrade HealthCare Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Topgrade HealthCare Recent Developments/Updates
   2.8 United Imaging
       2.8.1 United Imaging Details
       2.8.2 United Imaging Major Business
       2.8.3 United Imaging Positron Emission Tomography (PET) Product and Services
       2.8.4 United Imaging Positron Emission Tomography (PET) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 United Imaging Recent Developments/Updates

3 Competitive Environment: Positron Emission Tomography (PET) by Manufacturer

   3.1 Global Positron Emission Tomography (PET) Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Positron Emission Tomography (PET) Revenue by Manufacturer (2018-2023)
   3.3 Global Positron Emission Tomography (PET) Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Positron Emission Tomography (PET) by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Positron Emission Tomography (PET) Manufacturer Market Share in 2022
       3.4.2 Top 6 Positron Emission Tomography (PET) Manufacturer Market Share in 2022
   3.5 Positron Emission Tomography (PET) Market: Overall Company Footprint Analysis
       3.5.1 Positron Emission Tomography (PET) Market: Region Footprint
       3.5.2 Positron Emission Tomography (PET) Market: Company Product Type Footprint
       3.5.3 Positron Emission Tomography (PET) Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Positron Emission Tomography (PET) Market Size by Region
       4.1.1 Global Positron Emission Tomography (PET) Sales Quantity by Region (2018-2029)
       4.1.2 Global Positron Emission Tomography (PET) Consumption Value by Region (2018-2029)
       4.1.3 Global Positron Emission Tomography (PET) Average Price by Region (2018-2029)
   4.2 North America Positron Emission Tomography (PET) Consumption Value (2018-2029)
   4.3 Europe Positron Emission Tomography (PET) Consumption Value (2018-2029)
   4.4 Asia-Pacific Positron Emission Tomography (PET) Consumption Value (2018-2029)
   4.5 South America Positron Emission Tomography (PET) Consumption Value (2018-2029)
   4.6 Middle East and Africa Positron Emission Tomography (PET) Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   5.2 Global Positron Emission Tomography (PET) Consumption Value by Type (2018-2029)
   5.3 Global Positron Emission Tomography (PET) Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   6.2 Global Positron Emission Tomography (PET) Consumption Value by Application (2018-2029)
   6.3 Global Positron Emission Tomography (PET) Average Price by Application (2018-2029)

7 North America

   7.1 North America Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   7.2 North America Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   7.3 North America Positron Emission Tomography (PET) Market Size by Country
       7.3.1 North America Positron Emission Tomography (PET) Sales Quantity by Country (2018-2029)
       7.3.2 North America Positron Emission Tomography (PET) Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   8.2 Europe Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   8.3 Europe Positron Emission Tomography (PET) Market Size by Country
       8.3.1 Europe Positron Emission Tomography (PET) Sales Quantity by Country (2018-2029)
       8.3.2 Europe Positron Emission Tomography (PET) Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Positron Emission Tomography (PET) Market Size by Region
       9.3.1 Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Positron Emission Tomography (PET) Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   10.2 South America Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   10.3 South America Positron Emission Tomography (PET) Market Size by Country
       10.3.1 South America Positron Emission Tomography (PET) Sales Quantity by Country (2018-2029)
       10.3.2 South America Positron Emission Tomography (PET) Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Positron Emission Tomography (PET) Market Size by Country
       11.3.1 Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Positron Emission Tomography (PET) Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Positron Emission Tomography (PET) Market Drivers
   12.2 Positron Emission Tomography (PET) Market Restraints
   12.3 Positron Emission Tomography (PET) Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Positron Emission Tomography (PET) and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Positron Emission Tomography (PET)
   13.3 Positron Emission Tomography (PET) Production Process
   13.4 Positron Emission Tomography (PET) Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Positron Emission Tomography (PET) Typical Distributors
   14.3 Positron Emission Tomography (PET) Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Positron Emission Tomography (PET) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Positron Emission Tomography (PET) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. GE Basic Information, Manufacturing Base and Competitors
   Table 4. GE Major Business
   Table 5. GE Positron Emission Tomography (PET) Product and Services
   Table 6. GE Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. GE Recent Developments/Updates
   Table 8. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
   Table 9. Siemens Healthcare Major Business
   Table 10. Siemens Healthcare Positron Emission Tomography (PET) Product and Services
   Table 11. Siemens Healthcare Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Siemens Healthcare Recent Developments/Updates
   Table 13. Philips Healthcare Basic Information, Manufacturing Base and Competitors
   Table 14. Philips Healthcare Major Business
   Table 15. Philips Healthcare Positron Emission Tomography (PET) Product and Services
   Table 16. Philips Healthcare Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Philips Healthcare Recent Developments/Updates
   Table 18. Toshiba Basic Information, Manufacturing Base and Competitors
   Table 19. Toshiba Major Business
   Table 20. Toshiba Positron Emission Tomography (PET) Product and Services
   Table 21. Toshiba Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Toshiba Recent Developments/Updates
   Table 23. Hitachi Basic Information, Manufacturing Base and Competitors
   Table 24. Hitachi Major Business
   Table 25. Hitachi Positron Emission Tomography (PET) Product and Services
   Table 26. Hitachi Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Hitachi Recent Developments/Updates
   Table 28. Neusoft Basic Information, Manufacturing Base and Competitors
   Table 29. Neusoft Major Business
   Table 30. Neusoft Positron Emission Tomography (PET) Product and Services
   Table 31. Neusoft Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Neusoft Recent Developments/Updates
   Table 33. Topgrade HealthCare Basic Information, Manufacturing Base and Competitors
   Table 34. Topgrade HealthCare Major Business
   Table 35. Topgrade HealthCare Positron Emission Tomography (PET) Product and Services
   Table 36. Topgrade HealthCare Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Topgrade HealthCare Recent Developments/Updates
   Table 38. United Imaging Basic Information, Manufacturing Base and Competitors
   Table 39. United Imaging Major Business
   Table 40. United Imaging Positron Emission Tomography (PET) Product and Services
   Table 41. United Imaging Positron Emission Tomography (PET) Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. United Imaging Recent Developments/Updates
   Table 43. Global Positron Emission Tomography (PET) Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 44. Global Positron Emission Tomography (PET) Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 45. Global Positron Emission Tomography (PET) Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 46. Market Position of Manufacturers in Positron Emission Tomography (PET), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 47. Head Office and Positron Emission Tomography (PET) Production Site of Key Manufacturer
   Table 48. Positron Emission Tomography (PET) Market: Company Product Type Footprint
   Table 49. Positron Emission Tomography (PET) Market: Company Product Application Footprint
   Table 50. Positron Emission Tomography (PET) New Market Entrants and Barriers to Market Entry
   Table 51. Positron Emission Tomography (PET) Mergers, Acquisition, Agreements, and Collaborations
   Table 52. Global Positron Emission Tomography (PET) Sales Quantity by Region (2018-2023) & (K Units)
   Table 53. Global Positron Emission Tomography (PET) Sales Quantity by Region (2024-2029) & (K Units)
   Table 54. Global Positron Emission Tomography (PET) Consumption Value by Region (2018-2023) & (USD Million)
   Table 55. Global Positron Emission Tomography (PET) Consumption Value by Region (2024-2029) & (USD Million)
   Table 56. Global Positron Emission Tomography (PET) Average Price by Region (2018-2023) & (USD/Unit)
   Table 57. Global Positron Emission Tomography (PET) Average Price by Region (2024-2029) & (USD/Unit)
   Table 58. Global Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 59. Global Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 60. Global Positron Emission Tomography (PET) Consumption Value by Type (2018-2023) & (USD Million)
   Table 61. Global Positron Emission Tomography (PET) Consumption Value by Type (2024-2029) & (USD Million)
   Table 62. Global Positron Emission Tomography (PET) Average Price by Type (2018-2023) & (USD/Unit)
   Table 63. Global Positron Emission Tomography (PET) Average Price by Type (2024-2029) & (USD/Unit)
   Table 64. Global Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 65. Global Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 66. Global Positron Emission Tomography (PET) Consumption Value by Application (2018-2023) & (USD Million)
   Table 67. Global Positron Emission Tomography (PET) Consumption Value by Application (2024-2029) & (USD Million)
   Table 68. Global Positron Emission Tomography (PET) Average Price by Application (2018-2023) & (USD/Unit)
   Table 69. Global Positron Emission Tomography (PET) Average Price by Application (2024-2029) & (USD/Unit)
   Table 70. North America Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 71. North America Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 72. North America Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 73. North America Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 74. North America Positron Emission Tomography (PET) Sales Quantity by Country (2018-2023) & (K Units)
   Table 75. North America Positron Emission Tomography (PET) Sales Quantity by Country (2024-2029) & (K Units)
   Table 76. North America Positron Emission Tomography (PET) Consumption Value by Country (2018-2023) & (USD Million)
   Table 77. North America Positron Emission Tomography (PET) Consumption Value by Country (2024-2029) & (USD Million)
   Table 78. Europe Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 79. Europe Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 80. Europe Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 81. Europe Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 82. Europe Positron Emission Tomography (PET) Sales Quantity by Country (2018-2023) & (K Units)
   Table 83. Europe Positron Emission Tomography (PET) Sales Quantity by Country (2024-2029) & (K Units)
   Table 84. Europe Positron Emission Tomography (PET) Consumption Value by Country (2018-2023) & (USD Million)
   Table 85. Europe Positron Emission Tomography (PET) Consumption Value by Country (2024-2029) & (USD Million)
   Table 86. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 87. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 88. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 89. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 90. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Region (2018-2023) & (K Units)
   Table 91. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity by Region (2024-2029) & (K Units)
   Table 92. Asia-Pacific Positron Emission Tomography (PET) Consumption Value by Region (2018-2023) & (USD Million)
   Table 93. Asia-Pacific Positron Emission Tomography (PET) Consumption Value by Region (2024-2029) & (USD Million)
   Table 94. South America Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 95. South America Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 96. South America Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 97. South America Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 98. South America Positron Emission Tomography (PET) Sales Quantity by Country (2018-2023) & (K Units)
   Table 99. South America Positron Emission Tomography (PET) Sales Quantity by Country (2024-2029) & (K Units)
   Table 100. South America Positron Emission Tomography (PET) Consumption Value by Country (2018-2023) & (USD Million)
   Table 101. South America Positron Emission Tomography (PET) Consumption Value by Country (2024-2029) & (USD Million)
   Table 102. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Type (2018-2023) & (K Units)
   Table 103. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Type (2024-2029) & (K Units)
   Table 104. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Application (2018-2023) & (K Units)
   Table 105. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Application (2024-2029) & (K Units)
   Table 106. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Region (2018-2023) & (K Units)
   Table 107. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity by Region (2024-2029) & (K Units)
   Table 108. Middle East & Africa Positron Emission Tomography (PET) Consumption Value by Region (2018-2023) & (USD Million)
   Table 109. Middle East & Africa Positron Emission Tomography (PET) Consumption Value by Region (2024-2029) & (USD Million)
   Table 110. Positron Emission Tomography (PET) Raw Material
   Table 111. Key Manufacturers of Positron Emission Tomography (PET) Raw Materials
   Table 112. Positron Emission Tomography (PET) Typical Distributors
   Table 113. Positron Emission Tomography (PET) Typical Customers

List of Figures

   Figure 1. Positron Emission Tomography (PET) Picture
   Figure 2. Global Positron Emission Tomography (PET) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Positron Emission Tomography (PET) Consumption Value Market Share by Type in 2022
   Figure 4. PET-CT Examples
   Figure 5. PET-MR Examples
   Figure 6. Others Examples
   Figure 7. Global Positron Emission Tomography (PET) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Positron Emission Tomography (PET) Consumption Value Market Share by Application in 2022
   Figure 9. Oncology Examples
   Figure 10. Cardiology Examples
   Figure 11. Neurology Examples
   Figure 12. Others Examples
   Figure 13. Global Positron Emission Tomography (PET) Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 14. Global Positron Emission Tomography (PET) Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 15. Global Positron Emission Tomography (PET) Sales Quantity (2018-2029) & (K Units)
   Figure 16. Global Positron Emission Tomography (PET) Average Price (2018-2029) & (USD/Unit)
   Figure 17. Global Positron Emission Tomography (PET) Sales Quantity Market Share by Manufacturer in 2022
   Figure 18. Global Positron Emission Tomography (PET) Consumption Value Market Share by Manufacturer in 2022
   Figure 19. Producer Shipments of Positron Emission Tomography (PET) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 20. Top 3 Positron Emission Tomography (PET) Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Top 6 Positron Emission Tomography (PET) Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Global Positron Emission Tomography (PET) Sales Quantity Market Share by Region (2018-2029)
   Figure 23. Global Positron Emission Tomography (PET) Consumption Value Market Share by Region (2018-2029)
   Figure 24. North America Positron Emission Tomography (PET) Consumption Value (2018-2029) & (USD Million)
   Figure 25. Europe Positron Emission Tomography (PET) Consumption Value (2018-2029) & (USD Million)
   Figure 26. Asia-Pacific Positron Emission Tomography (PET) Consumption Value (2018-2029) & (USD Million)
   Figure 27. South America Positron Emission Tomography (PET) Consumption Value (2018-2029) & (USD Million)
   Figure 28. Middle East & Africa Positron Emission Tomography (PET) Consumption Value (2018-2029) & (USD Million)
   Figure 29. Global Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 30. Global Positron Emission Tomography (PET) Consumption Value Market Share by Type (2018-2029)
   Figure 31. Global Positron Emission Tomography (PET) Average Price by Type (2018-2029) & (USD/Unit)
   Figure 32. Global Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 33. Global Positron Emission Tomography (PET) Consumption Value Market Share by Application (2018-2029)
   Figure 34. Global Positron Emission Tomography (PET) Average Price by Application (2018-2029) & (USD/Unit)
   Figure 35. North America Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 36. North America Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 37. North America Positron Emission Tomography (PET) Sales Quantity Market Share by Country (2018-2029)
   Figure 38. North America Positron Emission Tomography (PET) Consumption Value Market Share by Country (2018-2029)
   Figure 39. United States Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Canada Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Mexico Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Europe Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 43. Europe Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 44. Europe Positron Emission Tomography (PET) Sales Quantity Market Share by Country (2018-2029)
   Figure 45. Europe Positron Emission Tomography (PET) Consumption Value Market Share by Country (2018-2029)
   Figure 46. Germany Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. France Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. United Kingdom Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Russia Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Italy Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 52. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 53. Asia-Pacific Positron Emission Tomography (PET) Sales Quantity Market Share by Region (2018-2029)
   Figure 54. Asia-Pacific Positron Emission Tomography (PET) Consumption Value Market Share by Region (2018-2029)
   Figure 55. China Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Japan Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Korea Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. India Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Southeast Asia Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Australia Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. South America Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 62. South America Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 63. South America Positron Emission Tomography (PET) Sales Quantity Market Share by Country (2018-2029)
   Figure 64. South America Positron Emission Tomography (PET) Consumption Value Market Share by Country (2018-2029)
   Figure 65. Brazil Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Argentina Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity Market Share by Type (2018-2029)
   Figure 68. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity Market Share by Application (2018-2029)
   Figure 69. Middle East & Africa Positron Emission Tomography (PET) Sales Quantity Market Share by Region (2018-2029)
   Figure 70. Middle East & Africa Positron Emission Tomography (PET) Consumption Value Market Share by Region (2018-2029)
   Figure 71. Turkey Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Egypt Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Saudi Arabia Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. South Africa Positron Emission Tomography (PET) Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. Positron Emission Tomography (PET) Market Drivers
   Figure 76. Positron Emission Tomography (PET) Market Restraints
   Figure 77. Positron Emission Tomography (PET) Market Trends
   Figure 78. Porters Five Forces Analysis
   Figure 79. Manufacturing Cost Structure Analysis of Positron Emission Tomography (PET) in 2022
   Figure 80. Manufacturing Process Analysis of Positron Emission Tomography (PET)
   Figure 81. Positron Emission Tomography (PET) Industrial Chain
   Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 83. Direct Channel Pros & Cons
   Figure 84. Indirect Channel Pros & Cons
   Figure 85. Methodology
   Figure 86. Research Process and Data Source